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ABSTRACT - Purpose. To measure the 
rosmarinic acid content of eight commercial 
tinctures derived from fresh (n= 5) and dried 
(n=3) Melissa officinalis herb. Methods. 
Rosmarinic acid and the internal standard 
(esculin) were purchased from Aldrich Chemical 
Co. The column used was a Luna C18, 5 μm (150 
x 4.6 mm I.D., Phenomenex) maintained at 
ambient room temperature. The HPLC system 
consisted of a Shimadzu SCL-6B controller, 
Shimadzu LC-6A pumps, Shimadzu SPD-6A UV 
single wavelength spectrophotometric detector set 
to 320 nm and Shimadzu SIL-6B autosampler. 
Gradient elution of the samples and standard were 
performed using ammonium formate (0.02 M; pH 
6.25 at 27 oC; eluent A) and methanol (eluent B). 
The gradient elution initial conditions were 2% of 
eluent B with linear gradient to 60% at 30 min, 
followed by linear gradient to 90% of eluent B at 
31 min, this proportion being maintained for 4 
min. The column was then returned to the initial 
condition at 36 min and maintained until the end 
of the run at 43 min. The flow rate was 1 mL/min. 
The assay was validated for sensitivity, accuracy 
and reproducibility. Results. The content of 
rosmarinic acid in commercial tinctures was 
significantly higher in the tinctures made from 
dried plant material (2.96 – 22.18 mg/mL) 
compared to fresh plant tinctures (<= 0.92 
mg/mL). Conclusion. These results have 
implications both for the manufacturers of 
commercial tinctures and also for herbal 
practitioners in the choice of tinctures for treating 
Herpes simplex infection. 
 
INTRODUCTION 
 
Tinctures, or hydroalcoholic solutions, of lemon 
balm herb (Melissa officinalis L.) are used in 
Western Herbal Medicine to treat cutaneous 
Herpes simplex infection as well as for 
carminative, diaphoretic and sedative actions  
 
 
(1,2). However, herbal practitioners are faced 
with commercial tinctures from either fresh or 
dried Melissa leaf, that vary widely in the drug-
to-extract ratio (ranging from 1:1 to 1:5) and 
alcohol concentration (25 to 45%), depending on 
the manufacturer (2). The phytochemistry of the 
essential oil, associated with the fresh leaf, is well 
known, albeit the total content of oil in the herbal 
drug is relatively low at 0.02-0.3% dry weight (3). 
Often, herbal practitioners consider the lemon 
scent, characteristic of fresh leaf, to be the main 
criterion of quality (4). The constituents 
responsible for this scent include geranial (citral 
A) and neral (citral B) (representing 45-90% of 
the oil) and R-(+)-citronellal (1-40%). It is the 
ratio of the content of geranial and neral (4:3), 
together with the presence of 6-methyl-5-heptene-
2-one, that are considered to be the main criteria 
of the authenticity of the oil (4). Besides these 
essential oil constituents, a wide range of non-
volatile bioactive compounds have also been 
reported. These include hydroxycinnamic acid 
derivatives (variously reported as 6-11%), 
primarily rosmarinic acid (2-7%), caffeic acid and 
chlorogenic acid (3-5) and flavonoids (0.5%) such 
as luteolin 3’-glucuronide (0.3%). The European 
Pharmacopoiea standard for dried Melissa leaf is 
not less than 4% hydroxycinnamic acid 
derivatives, expressed as rosmarinic acid 
derivatives, measured using spectophotometry 
(3). 
 Melissa leaf has a long history of use as a 
topical antiviral by herbal practitioners and it is 
variously used directly on the skin, or as either a 
1% tincture in cream, or dried aqueous extract in 
cream (1,2). The efficacy as a topical antiviral is 
supported by a couple of randomised, double-
blind, placebo controlled clinical studies on 
Herpes simplex skin lesions. 
________________________________________ 
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Such studies, primarily on Herpes labialis, have 
shown, significantly accelerated healing times (p 
< 0.05) compared with placebo (6-8).These trials 
involved treating lesions within 72 hours of the 
first symptoms, 2-4 times daily for 5-10 days, 
with a cream containing 1% of a lyophilised 
aqueous extract from dried Melissa leaf (70:1). 
One trial concluded that recurrence-free intervals 
were extended in comparison with topical 
virustatic preparations containing idoxuridine and 
tromantidine hydrochloride (9). 
 The antiviral activity of Melissa leaf in 
treating Herpes simplex infection has been 
reviewed elsewhere (10-13). Currently, antiviral 
research on M. officinalis has targeted the in-vitro 
activity against replication of the Herpes simplex 
virus type 1 and 2 (HSV-1 and HSV-2) (14, 15). 
Rosmarinic acid was also reported to inhibit the 
activities of both mutant and wild-type integrase 
of HIV-1 virus with IC50 values below 10 μM (16, 
17). However, regardless of the available 
scientific and clinical evidence for the role of 
dried Melissa leaf in a topical antiviral cream for 
treating Herpes simplex infection, there remains 
controversy amongst herbal practitioners as to 
whether fresh plant tinctures are more effective 
than those tinctures produced from dried plant 
material. The aim of this study was therefore to 
determine the rosmarinic acid content of 
commercial tinctures made from fresh and dried 
plant Melissa leaf.  
 
MATERIALS AND METHODS  
 
Chemicals 
Standards of rosmarinic acid and the internal 
standard (IS, esculin) were purchased from 
Aldrich Chemical Co. (Dorset, UK). Ammonium 
formate (Riedel-de Haën, Seelze, Germany) was 
purchased from Fluka, UK. HPLC-grade 
methanol (ACROS Organics, Geel, Belgium) was 
purchased from BDH (Dorset, UK). Water was 
purified using a Milli-Q Organex System from 
Millipore (Molsheim, France). Ammonium 
formate solution (0.02 M; pH 6.25 at 27 oC) was 
prepared. NMR-grade D2O for NMR experiments 
was supplied by Goss Scientific (Essex, UK). 
 
Tinctures 
Samples of either dried plant tinctures or specific 
(fresh plant) tinctures of M. officinalis L. were 
obtained from six companies commonly used by 
herbal practitioners in the UK. Test formulations 
from a particular manufacturer bore the same lot 
number and had an expiration date no earlier than 
2 years from the date of purchase. The samples 
were randomly labelled A-H and their identity 
was not known until after the analyses were 
complete. For comparison, a fresh tincture was 
prepared (18) in our laboratory from fresh M. 
officinalis L. harvested from one of the author’s 
(CJE) garden in Cheshunt, Hertfordshire on 
10/05/06. The tincture was prepared within 2 h of 
harvest. Twenty grams of fresh Melissa officinalis 
herb (leaf and stem) were ground in a pestle and 
mortar for 1 min, after which 40 mL of 
EtOH:H2O (45:55) was added and the resulting 
mixture triturated for a further 10 min. The green 
liquid was decanted off and filtered.  
 
Sample preparation for HPLC  
Eight commercial tinctures (Samples A-H) of 
lemon balm (Melissa officinalis) were used in this 
study. Comparison of rosmarinic acid content was 
standardised on the basis of milligrams of 
rosmarinic acid per mL of tincture. Thirty μL of 
tincture was added to 970 μL of methanol. Two 
hundred μL of each solution were added to 200 
μL of esculin (100 μg/mL in 0.02 M ammonium 
formate) solution. The resultant solutions were 
centrifuged at 13,000 min-1 for 5 min before 
injecting 20 μL on the HPLC system. Samples 
were freshly prepared daily. 
 
Preparation of NMR samples  
Tincture A-H (1 mL) was placed in a 1.5 mL 
Eppendorf microfuge tube and the open tubes 
were placed in an Eppendorf Thermomixer at 35 
oC for 18 h. Aliquots (100 μL) of the resulting 
dark brown solutions were added to 500 μL of 
D2O in a 1.5 mL Eppendorf microfuge tube and 
the resultant liquid was centrifuged at 15,000 
revolutions min-1 for 5 min. The supernatant 
liquid was pipetted into clean, dry 5 mm NMR 
tubes. 
 
HPLC instrumentation 
The quantification of samples and the calibration 
curves were performed using a high performance 
liquid chromatography system consisting of a 
Shimadzu SCL-6B controller, Shimadzu LC-6A 
pumps, Shimadzu SPD-6A UV single wavelength 
spectrophotometric detector and Shimadzu SIL-
6B autosampler. The UV detector was set at 320 
nm and data was acquired using Bruker Hystar 
software v2.1 (Bruker Biospin, Germany). The 
column used was a Luna C18, 5 μm (150 x 4.6 mm 
I.D., Phenomenex) maintained at ambient room 
temperature. Gradient elution of the samples and 
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standard were performed using ammonium 
formate 0.02 M at pH 6.25 (eluent A) and 
methanol (eluent B). The gradient elution was 
performed as follows: initial conditions were 2% 
of eluent B with linear gradient to 60% at 30 min, 
followed by linear gradient to 90% of eluent B at 
31 min, this proportion being maintained for 4 
min. The column was then returned to the initial 
condition at 36 min and maintained until the end 
of the run at 43 min. The flow rate was 1 mL/min. 
The sample injection volume was 20 μL: two 
injections were performed for each sample and 
standard. 
 
1H-NMR Spectroscopy 
All NMR spectra were acquired on a Bruker 
(Bruker GmbH, Rheinstein, Germany) DRX 500 
Spectrometer, operating at 500.13 MHz for the 1H 
frequency. Spectra were the result of the 
summation of 128 free induction decays (FIDs), 
with data collected into 32K datapoints, and a 
sweep width of 14 ppm. Acquisition time was 
2.34 s. The water signal was suppressed using a 
standard 1D-pulse sequence. Prior to Fourier 
transformation, an exponential line broadening 
equivalent to 0.3 Hz was applied to the FIDs. 
Spectra were referenced to the ethanol triplet 
centred at 1.05 ppm.  
 
Quantitation of rosmarinic acid 
Rosmarinic acid calibration curves (n=4) were 
obtained by preparing stock solutions (1000 
μg/mL) in methanol. Subsequent dilutions were 
made to give 200, 100, 50, 25, 12.5 and 6.25 
μg/mL. 200 μL of each solution were added to 
200 μL of Esculin, IS (100 μg/mL in 0.02 M 
ammonium formate) solution. After mixing, 20 
μL of each final concentration were injected in 
duplicate. Stock solutions and dilutions were 
prepared fresh daily. The linearity of the 
calibration curves was determined (r2>0.99). The 
limit of detection (LOD) was calculated based on 
a signal-to-noise ratio (S/N: 3.3). The limit of 
quantitation (LOQ) was then calculated based on 
the signal-to-noise ratio (S/N: 10) using the 
lowest concentration in the calibration and the 
highest noise observed when injecting a blank 
(19). The intraday precision was calculated by 
comparison of the area obtained for 12 injections 
of Esculin solution (50 μg/mL) in 0.02 M 
ammonium formate (pH 6.25) on two different 
days. For the interday precision, the ratio of the 
area of rosmarinic acid/area of esculin for all the 
points in the calibration curve for the different 
days were summed and compared. 
 
RESULTS 
 
1H NMR spectroscopy 
The 1H NMR spectra of the Melissa samples from 
the 8 different manufacturers are presented in 
Figure 1.  
 It can be seen that there is a wide range of 
concentrations across the samples. From the 
sample B spectrum, it was possible to discern 
several signals in the aromatic region (δ 6-8) that 
correspond theoretically to those of rosmarinic 
acid. The addition of rosmarinic acid standard 
then confirmed rosmarinic acid as a major 
constituent of some of the samples. Two 
distinctive signals for H7 and H8 are represented 
by two 1H doublets with J = 16 Hz at δ 6.1 and 
7.4 respectively. H2 is represented by a 2 Hz 
doublet integrating for 1H at δ 7.0. The signals 
representing H5, H6, H2’, H5’ and H6’ are 
overlapped in the region δ 6.6 to 6.9. A semi-
quantitative ranking from high to low rosmarinic 
acid content was B > C > E , all were dried plant 
tinctures. Samples A, D, F, G and H, all from 
fresh plant tinctures, contained significantly less 
than the former. Because of the considerable 
overlap of NMR signals, further quantification of 
rosmarinic acid was carried out by HPLC-UV. 
 
HPLC-UV determination of rosmarinic acid 
The HPLC-UV320nm chromatograms for samples A 
to H are illustrated in Figure 2. Retention times 
(tR) were 15.5 min and 22.5 min for esculin and 
rosmarinic acid, respectively. The ranking of the 
samples in terms of rosmarinic acid concentration 
confirmed the semi-quantitative ranking already 
obtained by NMR spectroscopy. The 
quantification of the rosmarinic acid was acquired 
using peak area ratios of rosmarinic acid to 
internal standard. Esculin was chosen as internal 
standard as previous injections of the sample 
showed no major peaks in the samples at esculin 
tR (15.5 min). The histogram in Figure 3 
illustrates the data of the resulting concentrations 
of RA between the 8 commercial preparations. 
The amount of rosmarinic acid (mg/mL Mean ± 
SD) present in batches was A (0.15 ± 0.01); B 
(22.18 ± 1.03); C (1.41 ± 0.09); D (0.92 ± 0.11); 
E (2.96 ± 0.42); F (0.19 ± 0.03); G (< LOD of 
0.06); H (0.47 ± 0.04). Linearity of the calibration 
curves was determined (r2 > 0.99), confirming the 
linearity of the analytical method.  
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Figure 1. 500MHz 1H NMR spectra of commercial tinctures (A-H) derived from fresh and dried 
Melissa officinalis.  
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Figure 2. HPLC-UV320nm chromatograms of commerical tinctures (A-H) produced from fresh and 
dried Melissa officinalis. Retention times of esculin and rosmarinic acid were observed at 15.5 and 
22.5min respectively. 
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Concentration of rosmarinic acid in commercial tinctures 
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Figure 3. Rosmarinic acid content in commercial tinctures made from fresh and dried plant material. 
 
 
The intraday precision was calculated by 
comparison of the area obtained for 12 injections 
of esculin solution (50 μg/mL) in 0.02 M 
ammonium formate (pH 6.25) on two separate 
days and the resulting coefficient of variation 
obtained (CV) was 1.98 and 2.28%. For the 
interday precision, the ratio of the area of 
rosmarinic acid/area of esculin for all the points in 
the calibration curve for the different days were 
added up and compared. The resulting CV 
obtained was 5.60%. The accuracy of the method 
was calculated after six injections of known 
concentration of rosmarinic acid (50 μg/mL) were 
carried out on three different days and were 
compared with the measured concentration (50 ± 
3.20μg/mL) of rosmarinic acid. The mean of the 
determined values showed a variation of 1.9% 
with respect to the known values; this together 
with the low standard deviation observed 
supported the accuracy of the analytical method. 
CVs smaller than ±15% of the measured value  
 
with respect to the known value reflect good 
accuracy of the method (19). The LOD (S/N: 3.3) 
and the LOQ (S/N:10) for rosmarinic acid using 
the developed method were 61 ng/mL and 185 
ng/mL, respectively. 
 
DISCUSSION 
 
Due to relatively lax regulation of herbal products 
in the UK and abroad, commercial tincture 
products may contain significant differences in 
chemical composition. Concerning Melissa 
products, herbal practitioners in the UK are thus 
faced with a wide range of commercial tinctures, 
from either fresh or dried Melissa leaf, that vary 
widely in the drug-to-extract ratio (1:2 to 1:5) 
depending on the manufacturer (2). The 
concentration of alcohol used for Melissa 
tinctures typically ranges from 45% down to 25%. 
Taken together, this variability in drug-to-extract 
ratio and the range of alcohol concentrations may 
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partly explain the differential extraction of plant 
constituents, a common source of variability 
between commercial tinctures. Variability within 
and between batches can result from different 
methods of cultivation, extraction, seasonal 
factors, time of harvesting, storage conditions and 
natural intraspecific variation in Melissa leaf (4, 
20). A further compounding factor is the 
manufacturing process: cold maceration or 
percolation being two preferred methods (2). 
Importantly, much of the official international 
pharmacopoeia data on Melissa leaf refers almost 
exclusively to dried plant. Although GMP 
regulations cover the manufacturing process they 
do not necessarily specify the quality of the 
starting plant material, nor whether fresh or dried 
is to be used. This state of regulation has therefore 
led to the wide range in quality of Melissa 
products that face herbal practitioners in the UK. 
However, the professional regulation of herbal 
practice is currently under review in the UK, and 
with the underlying principle of evidence-based 
practice informing primary healthcare, 
qualification of herbal practitioners arguably 
should involve an understanding of the 
pharmacological and pharmacodynamic basis of 
herbal medicine. 
 In general, fresh plant tinctures may 
contain lower amounts of bioactive principles due 
to a water content of typically 75 to 90%, 
resulting in a marked dilution effect (2). 
References to dried extracts are common in the 
British Herbal Pharmacopoiea, whereas fresh 
extracts are less frequently described (18). In the 
main, unless the bioactive components are 
volatile constituents, dried material has benefits in 
terms of storage and availability. Recent 
empirical research on greater celandine extracts 
indicated that fresh plant tinctures contain less 
total alkaloid content than dried counterparts (21). 
Despite this scientific evidence, many herbal 
practitioners still consider some fresh plant 
extracts such as greater celandine and Galium 
aparine to have superior activity. 
 Tincture products are popular with herbal 
practitioners because of availability, ease of 
dosage and for convenient storage. However, little 
research has been done on the chemical stability 
of tinctures due to the challenging multi-
component nature of such analyses. Gafner and 
Bergeron (22) provide an excellent review of the 
environmental factors affecting chemical stability 
include pH, light and temperature. Fresh plant 
material is more susceptible to enzymatic 
degradation than is dried. The presence of air in 
tincture products can lead to oxidation whilst the 
presence of metal ions mainly iron, copper and 
other transition metals, may cause hydrolysis and 
oxidation reactions with redox active molecules. 
Amber vials widely used to store tincture 
products contain significantly higher amounts of 
iron and titanium and may lead to leaching of 
metals leading to oxidation over a long storage 
period. Similarly, the presence of high levels of 
water has been shown in many studies to cause a 
more rapid decrease in important biomarker 
compounds. An important paper by Bilia and 
colleagues (23) reported a half life of only 3 
months for the purported bioactive silymarin 
complex in alcoholic tincture products of 
Milkthistle, as measured by LC-DAD and LC-
MS. This has serious implications for storage and 
labelling of tincture products.  
 The validation of LC-DAD methods for 
the analysis of important biomarkers in tincture 
products is reported mainly by academic groups 
as opposed to herbal manufacturers (22). This 
instrumentation and the associated methods are 
widely available, requiring little intellectual input 
and are highly automated. New EMEA guidelines 
highlight the use of chromatographic or 
spectroscopic patterns, the so-called 
metabolomics approach (24-26), as an important 
evolving technology. The use of NMR 
spectroscopy in metabolomics provides an 
opportunity of unrivalled potential to explore 
plant metabolism. This is reflected in the number 
of recent publications using NMR in a variety of 
applications as reviewed by Holmes et al 2006 
(26). However, the level of expertise needed for 
the interpretation of NMR spectra is not widely 
available in the herbal industry, but sits more 
comfortably with the pharmaceutical industry 
(27). Here we illustrate the use of 1H NMR 
spectroscopy as a rapid profiling tool for 
identifying rosmarinic acid as an important 
biomarker of antiviral activity in Melissa tincture 
products. 
 Traditionally, the choice of fresh or dried 
Melissa officinalis by herbalists has depended on 
the season. Differentiation of use between 
tinctures prepared from fresh or dried material has 
generally been based on personal preference 
rather than scientific evidence. Since there is 
currently no standardisation of methods for the 
preparation of phytomedicines, particularly 
tinctures that are administered as the ingredients 
of many herbalists’ formulations, the choice of 
fresh or dried plant material has in the main been 
influenced by demand. The use of Melissa 
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officinalis as a topical antiviral is a relatively new 
application not mentioned in old herbals. Its use 
as such was confirmed by a series of 
comprehensive trials carried out in Germany (7) 
using a cream containing a dried extract from 
Melissa officinalis. The results of our study show 
that the use of fresh and dried plant material 
clearly affected the resultant constituent profile of 
the commercial tincture extracts, raising concern 
not only of potency but also of efficacy in terms 
of the compounds required to achieve a 
therapeutic effect. Due to their higher polyphenol 
content, i.e., rosmarinic acid, tinctures made from 
dried plant material are likely to be more effective 
as an antiviral than those made from the fresh 
plant, perhaps explaining, given their penchant for 
fresh plant tinctures, many herbalists’ reported 
lack of success in treating herpes sores. 
 Due to a paucity of scientific research 
medical herbalists still, to a large degree, rely on 
anecdotal evidence in their prescribing of plant 
remedies. There is however, now a growing need 
to establish a scientific evidence base for the 
practice of herbal medicine to help herbalists to 
be more discriminatory in their choice of 
products. Additionally, in regard to quality, with 
currently no standardised methods of production 
or accepted measure in place for the manufacture 
of tinctures for use by herbalists in their 
prescribing there is no guarantee of potency or 
efficacy. There is thus an urgent need for a review 
by manufacturers of their production procedures 
of the herbs formulated as tinctures that are 
popularly used by herbal practitioners. 
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